| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Water Pollutants, Chemical | 2 | 2025 | 41 | 1.760 |
Why?
|
| Mouth Neoplasms | 2 | 2024 | 97 | 1.530 |
Why?
|
| Zebrafish | 2 | 2025 | 417 | 1.510 |
Why?
|
| Embryo, Nonmammalian | 2 | 2025 | 145 | 1.090 |
Why?
|
| Trans-Activators | 14 | 2021 | 712 | 0.990 |
Why?
|
| Polysaccharides | 3 | 2021 | 148 | 0.960 |
Why?
|
| Guaiacol | 1 | 2025 | 1 | 0.950 |
Why?
|
| Cartilage | 1 | 2025 | 51 | 0.930 |
Why?
|
| Plasticizers | 1 | 2024 | 3 | 0.910 |
Why?
|
| Nuclear Receptor Coactivator 1 | 11 | 2019 | 162 | 0.910 |
Why?
|
| Phthalic Acids | 1 | 2024 | 9 | 0.910 |
Why?
|
| Chondrogenesis | 1 | 2024 | 28 | 0.890 |
Why?
|
| Gracilaria | 2 | 2021 | 2 | 0.870 |
Why?
|
| Nuclear Receptor Coactivator 3 | 16 | 2018 | 259 | 0.860 |
Why?
|
| Methyltransferases | 1 | 2024 | 81 | 0.840 |
Why?
|
| Cisplatin | 1 | 2024 | 282 | 0.790 |
Why?
|
| Odorants | 2 | 2020 | 83 | 0.790 |
Why?
|
| Craniofacial Abnormalities | 1 | 2024 | 253 | 0.780 |
Why?
|
| Reactive Oxygen Species | 2 | 2025 | 516 | 0.780 |
Why?
|
| Carps | 5 | 2019 | 9 | 0.720 |
Why?
|
| Oxidative Stress | 2 | 2025 | 803 | 0.680 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2024 | 767 | 0.670 |
Why?
|
| Soy Foods | 1 | 2020 | 3 | 0.660 |
Why?
|
| Animals | 71 | 2025 | 34789 | 0.660 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2015 | 323 | 0.660 |
Why?
|
| Mice | 59 | 2025 | 18461 | 0.630 |
Why?
|
| Histone Acetyltransferases | 10 | 2008 | 227 | 0.630 |
Why?
|
| Energy Metabolism | 1 | 2024 | 785 | 0.620 |
Why?
|
| Fish Diseases | 4 | 2019 | 11 | 0.600 |
Why?
|
| Colitis | 1 | 2021 | 165 | 0.600 |
Why?
|
| Twist-Related Protein 1 | 6 | 2023 | 39 | 0.580 |
Why?
|
| Mice, Knockout | 27 | 2025 | 3860 | 0.570 |
Why?
|
| Nuclear Proteins | 9 | 2025 | 1280 | 0.560 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 620 | 0.530 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1610 | 0.510 |
Why?
|
| CRISPR-Cas Systems | 4 | 2024 | 294 | 0.470 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2025 | 2056 | 0.470 |
Why?
|
| Mice, Transgenic | 15 | 2024 | 2444 | 0.450 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 1825 | 0.450 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 2 | 2024 | 32 | 0.400 |
Why?
|
| Prostatic Neoplasms | 7 | 2019 | 1576 | 0.390 |
Why?
|
| Cell Differentiation | 10 | 2025 | 1960 | 0.380 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2018 | 633 | 0.370 |
Why?
|
| Reoviridae | 4 | 2019 | 39 | 0.370 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2015 | 43 | 0.370 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 2438 | 0.360 |
Why?
|
| Cell Line, Tumor | 13 | 2025 | 3678 | 0.350 |
Why?
|
| Mice, Inbred BALB C | 3 | 2024 | 1045 | 0.340 |
Why?
|
| Reoviridae Infections | 3 | 2019 | 8 | 0.340 |
Why?
|
| Gene Editing | 3 | 2024 | 211 | 0.340 |
Why?
|
| Transcription Factors | 13 | 2021 | 2493 | 0.340 |
Why?
|
| Breast Neoplasms | 11 | 2016 | 2645 | 0.340 |
Why?
|
| Taste | 2 | 2020 | 31 | 0.330 |
Why?
|
| Fermentation | 2 | 2021 | 69 | 0.330 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2015 | 35 | 0.310 |
Why?
|
| Stem Cells | 5 | 2021 | 732 | 0.290 |
Why?
|
| Phosphoproteins | 3 | 2018 | 442 | 0.280 |
Why?
|
| Cell Movement | 6 | 2025 | 888 | 0.280 |
Why?
|
| Cell Proliferation | 8 | 2025 | 2507 | 0.270 |
Why?
|
| Liver | 4 | 2021 | 1796 | 0.270 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2025 | 448 | 0.250 |
Why?
|
| Mice, Nude | 2 | 2025 | 750 | 0.250 |
Why?
|
| RANK Ligand | 2 | 2025 | 54 | 0.250 |
Why?
|
| Growth Hormone | 1 | 2006 | 129 | 0.240 |
Why?
|
| Cyclin A2 | 1 | 2025 | 5 | 0.230 |
Why?
|
| Repressor Proteins | 5 | 2012 | 812 | 0.230 |
Why?
|
| Coix | 1 | 2025 | 1 | 0.230 |
Why?
|
| Carrageenan | 1 | 2025 | 6 | 0.230 |
Why?
|
| Neural Crest | 1 | 2025 | 54 | 0.230 |
Why?
|
| Glutens | 1 | 2025 | 10 | 0.230 |
Why?
|
| X-linked Nuclear Protein | 1 | 2025 | 17 | 0.230 |
Why?
|
| Triticum | 1 | 2025 | 34 | 0.230 |
Why?
|
| Growth Disorders | 1 | 2006 | 191 | 0.230 |
Why?
|
| Plant Oils | 1 | 2025 | 34 | 0.220 |
Why?
|
| Seeds | 1 | 2025 | 39 | 0.220 |
Why?
|
| Wnt Signaling Pathway | 1 | 2025 | 205 | 0.210 |
Why?
|
| Skull | 1 | 2025 | 143 | 0.210 |
Why?
|
| Embryonic Stem Cells | 3 | 2009 | 167 | 0.210 |
Why?
|
| Sonication | 2 | 2020 | 9 | 0.210 |
Why?
|
| Male | 32 | 2024 | 64910 | 0.210 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2015 | 240 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2009 | 323 | 0.210 |
Why?
|
| Osteoblasts | 1 | 2025 | 161 | 0.210 |
Why?
|
| DNA Helicases | 1 | 2025 | 239 | 0.200 |
Why?
|
| Hypothalamus | 3 | 2023 | 210 | 0.200 |
Why?
|
| Serine | 2 | 2016 | 166 | 0.200 |
Why?
|
| Uterus | 4 | 2012 | 548 | 0.190 |
Why?
|
| Spermatogenesis | 3 | 2015 | 176 | 0.190 |
Why?
|
| Signal Transduction | 9 | 2021 | 4703 | 0.190 |
Why?
|
| Mammary Glands, Animal | 7 | 2013 | 453 | 0.190 |
Why?
|
| Oocytes | 2 | 2024 | 290 | 0.190 |
Why?
|
| Cyprinidae | 1 | 2021 | 1 | 0.190 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 280 | 0.180 |
Why?
|
| Hypoglycemia | 1 | 2023 | 183 | 0.180 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 10 | 0.180 |
Why?
|
| Phenylketonurias | 1 | 2021 | 14 | 0.180 |
Why?
|
| Cloning, Molecular | 2 | 2018 | 811 | 0.180 |
Why?
|
| Sargassum | 1 | 2021 | 1 | 0.180 |
Why?
|
| Insulin-Secreting Cells | 2 | 2015 | 146 | 0.170 |
Why?
|
| Phenylalanine | 1 | 2021 | 123 | 0.170 |
Why?
|
| Citrus | 1 | 2020 | 7 | 0.170 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2021 | 60 | 0.170 |
Why?
|
| Glycoside Hydrolases | 1 | 2020 | 17 | 0.170 |
Why?
|
| Neuroendocrine Cells | 1 | 2021 | 10 | 0.170 |
Why?
|
| Memory | 1 | 2024 | 356 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2021 | 810 | 0.170 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2017 | 138 | 0.170 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 46 | 0.170 |
Why?
|
| Female | 39 | 2024 | 70623 | 0.170 |
Why?
|
| Zygosaccharomyces | 1 | 2020 | 1 | 0.170 |
Why?
|
| Enterococcaceae | 1 | 2020 | 1 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 663 | 0.170 |
Why?
|
| Neoplasms | 4 | 2023 | 2955 | 0.170 |
Why?
|
| Epithelial-Mesenchymal Transition | 5 | 2025 | 241 | 0.160 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2020 | 67 | 0.160 |
Why?
|
| Estradiol | 4 | 2015 | 487 | 0.160 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 685 | 0.160 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 210 | 0.160 |
Why?
|
| HEK293 Cells | 6 | 2022 | 799 | 0.160 |
Why?
|
| Galectin 1 | 1 | 2019 | 2 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 169 | 0.160 |
Why?
|
| Osteoclasts | 2 | 2025 | 72 | 0.160 |
Why?
|
| Apoptosis | 7 | 2018 | 1891 | 0.160 |
Why?
|
| Humans | 33 | 2025 | 131985 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 101 | 0.160 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 1881 | 0.160 |
Why?
|
| Macrophage Colony-Stimulating Factor | 3 | 2014 | 17 | 0.150 |
Why?
|
| Neoplasm Metastasis | 3 | 2015 | 719 | 0.150 |
Why?
|
| Fertilization in Vitro | 1 | 2020 | 161 | 0.150 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2019 | 8 | 0.150 |
Why?
|
| Trachea | 1 | 2021 | 210 | 0.150 |
Why?
|
| Hypoxia | 1 | 2021 | 258 | 0.150 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 1015 | 0.150 |
Why?
|
| Androgens | 2 | 2018 | 277 | 0.150 |
Why?
|
| Embryonic Development | 1 | 2020 | 215 | 0.150 |
Why?
|
| Submandibular Gland | 1 | 2018 | 6 | 0.150 |
Why?
|
| Glucose | 1 | 2023 | 870 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 632 | 0.150 |
Why?
|
| Serpins | 1 | 2018 | 34 | 0.150 |
Why?
|
| Organ Specificity | 3 | 2013 | 412 | 0.150 |
Why?
|
| Integrin beta1 | 1 | 2018 | 56 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2025 | 1131 | 0.150 |
Why?
|
| Nuclear Receptor Coactivators | 4 | 2015 | 61 | 0.150 |
Why?
|
| Epithelial Cells | 5 | 2018 | 903 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2018 | 44 | 0.140 |
Why?
|
| Virus Internalization | 1 | 2018 | 60 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 305 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2021 | 240 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 624 | 0.140 |
Why?
|
| Crosses, Genetic | 4 | 2019 | 162 | 0.140 |
Why?
|
| Transcription Factor AP-1 | 2 | 2015 | 110 | 0.140 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 69 | 0.140 |
Why?
|
| Morphogenesis | 3 | 2018 | 203 | 0.140 |
Why?
|
| Colon | 1 | 2021 | 370 | 0.140 |
Why?
|
| Cardiomegaly | 1 | 2018 | 125 | 0.140 |
Why?
|
| RNA, Messenger | 7 | 2012 | 2674 | 0.140 |
Why?
|
| Th17 Cells | 1 | 2018 | 97 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2015 | 148 | 0.130 |
Why?
|
| Prealbumin | 2 | 2008 | 29 | 0.130 |
Why?
|
| Oxygen | 1 | 2021 | 569 | 0.130 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 159 | 0.130 |
Why?
|
| Cell Plasticity | 1 | 2017 | 36 | 0.130 |
Why?
|
| Feces | 1 | 2021 | 755 | 0.130 |
Why?
|
| Prognosis | 2 | 2025 | 5008 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 852 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2019 | 413 | 0.130 |
Why?
|
| Neurons | 3 | 2024 | 1998 | 0.130 |
Why?
|
| Fishes | 1 | 2016 | 35 | 0.130 |
Why?
|
| RNA, Viral | 1 | 2018 | 562 | 0.120 |
Why?
|
| Actins | 1 | 2018 | 334 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 445 | 0.120 |
Why?
|
| Obesity | 3 | 2022 | 2394 | 0.120 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 1535 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 347 | 0.120 |
Why?
|
| Estrogens | 2 | 2012 | 435 | 0.120 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 1422 | 0.120 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 49 | 0.120 |
Why?
|
| Receptors, Estrogen | 4 | 2009 | 728 | 0.120 |
Why?
|
| MafB Transcription Factor | 1 | 2015 | 1 | 0.120 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2015 | 2 | 0.120 |
Why?
|
| Sexual Behavior, Animal | 1 | 2015 | 63 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 8 | 2011 | 4752 | 0.120 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2016 | 123 | 0.120 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 346 | 0.110 |
Why?
|
| Protein Binding | 5 | 2021 | 1730 | 0.110 |
Why?
|
| Cytokines | 1 | 2021 | 1359 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 135 | 0.110 |
Why?
|
| Leptin | 2 | 2019 | 219 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2013 | 5 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 660 | 0.110 |
Why?
|
| Gene Expression | 6 | 2013 | 1558 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 257 | 0.110 |
Why?
|
| Bufanolides | 1 | 2014 | 13 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 246 | 0.110 |
Why?
|
| Body Weight | 4 | 2019 | 994 | 0.110 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 58 | 0.110 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 2 | 2024 | 15 | 0.100 |
Why?
|
| Embryo Implantation | 2 | 2012 | 231 | 0.100 |
Why?
|
| Gene Knockout Techniques | 4 | 2018 | 136 | 0.100 |
Why?
|
| Myocardium | 1 | 2018 | 907 | 0.100 |
Why?
|
| Health | 1 | 2013 | 35 | 0.100 |
Why?
|
| Hair Follicle | 1 | 2013 | 35 | 0.100 |
Why?
|
| Hepatocytes | 2 | 2021 | 237 | 0.100 |
Why?
|
| Reproduction | 1 | 2015 | 226 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2025 | 916 | 0.100 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2012 | 36 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 443 | 0.100 |
Why?
|
| Cell Line | 5 | 2021 | 2719 | 0.100 |
Why?
|
| Serotonin | 2 | 2024 | 212 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 361 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 200 | 0.090 |
Why?
|
| Receptors, Androgen | 4 | 2019 | 409 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2019 | 601 | 0.090 |
Why?
|
| Receptors, Somatotropin | 1 | 2011 | 9 | 0.090 |
Why?
|
| Phylogeny | 3 | 2019 | 763 | 0.090 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 687 | 0.090 |
Why?
|
| Integrin alpha5 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Liver Regeneration | 1 | 2011 | 39 | 0.090 |
Why?
|
| Aging | 3 | 2015 | 1248 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 89 | 0.090 |
Why?
|
| Embryo, Mammalian | 3 | 2018 | 440 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 109 | 0.080 |
Why?
|
| Receptor, ErbB-2 | 2 | 2011 | 515 | 0.080 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2010 | 15 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 518 | 0.080 |
Why?
|
| Lactation | 1 | 2011 | 198 | 0.080 |
Why?
|
| Fertility | 1 | 2012 | 258 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2003 | 571 | 0.080 |
Why?
|
| MCF-7 Cells | 3 | 2015 | 215 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2010 | 77 | 0.080 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 25 | 0.080 |
Why?
|
| Cell Division | 4 | 2004 | 743 | 0.080 |
Why?
|
| Hydroxycholecalciferols | 1 | 2009 | 6 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2011 | 292 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 1284 | 0.080 |
Why?
|
| Cells, Cultured | 5 | 2018 | 3037 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 1694 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 1977 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2021 | 792 | 0.070 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 135 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 90 | 0.070 |
Why?
|
| Exons | 2 | 2018 | 805 | 0.070 |
Why?
|
| Fish Proteins | 2 | 2019 | 6 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 137 | 0.070 |
Why?
|
| Disease Progression | 5 | 2018 | 2222 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 282 | 0.070 |
Why?
|
| RNA Interference | 3 | 2015 | 514 | 0.070 |
Why?
|
| Chromatin | 2 | 2018 | 518 | 0.070 |
Why?
|
| Immunoblotting | 3 | 2015 | 301 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2021 | 378 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 282 | 0.070 |
Why?
|
| Dwarfism | 1 | 2008 | 103 | 0.070 |
Why?
|
| Alleles | 3 | 2019 | 1685 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2009 | 271 | 0.060 |
Why?
|
| Heterozygote | 3 | 2019 | 713 | 0.060 |
Why?
|
| Pregnancy | 5 | 2020 | 7543 | 0.060 |
Why?
|
| Infertility, Male | 1 | 2009 | 296 | 0.060 |
Why?
|
| Histones | 1 | 2009 | 534 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 429 | 0.060 |
Why?
|
| Human Growth Hormone | 1 | 2006 | 75 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2009 | 1047 | 0.060 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 206 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 482 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2025 | 13 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2025 | 13 | 0.060 |
Why?
|
| Emulsions | 1 | 2025 | 70 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 494 | 0.060 |
Why?
|
| Protein Interaction Maps | 1 | 2025 | 90 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 761 | 0.060 |
Why?
|
| Gels | 1 | 2025 | 72 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2015 | 60 | 0.060 |
Why?
|
| Bone Development | 1 | 2025 | 55 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2004 | 77 | 0.060 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2004 | 86 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2025 | 141 | 0.050 |
Why?
|
| Insulin | 1 | 2009 | 1168 | 0.050 |
Why?
|
| Testis | 2 | 2004 | 422 | 0.050 |
Why?
|
| Zygote | 1 | 2024 | 30 | 0.050 |
Why?
|
| Cell Count | 2 | 2021 | 233 | 0.050 |
Why?
|
| Genotype | 3 | 2008 | 2697 | 0.050 |
Why?
|
| Sertoli Cells | 1 | 2004 | 79 | 0.050 |
Why?
|
| Genes, ras | 1 | 2004 | 100 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2006 | 301 | 0.050 |
Why?
|
| Growth | 1 | 2004 | 95 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4683 | 0.050 |
Why?
|
| Anoctamins | 1 | 2023 | 14 | 0.050 |
Why?
|
| Rats | 2 | 2021 | 3608 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2024 | 67 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2015 | 247 | 0.050 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2023 | 24 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 176 | 0.050 |
Why?
|
| Cerebellar Cortex | 1 | 2003 | 20 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 338 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2015 | 731 | 0.050 |
Why?
|
| Gene Targeting | 3 | 2013 | 173 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2020 | 1122 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2002 | 77 | 0.050 |
Why?
|
| Homeostasis | 2 | 2019 | 722 | 0.050 |
Why?
|
| Mutation | 3 | 2024 | 6227 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2025 | 385 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 213 | 0.050 |
Why?
|
| Lac Operon | 1 | 2002 | 92 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2011 | 1608 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2002 | 37 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2002 | 55 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2002 | 144 | 0.050 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 11 | 0.050 |
Why?
|
| Introns | 1 | 2002 | 305 | 0.050 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2014 | 102 | 0.040 |
Why?
|
| Photolysis | 1 | 2021 | 12 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 1 | 2021 | 20 | 0.040 |
Why?
|
| Acetylation | 1 | 2021 | 191 | 0.040 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2021 | 26 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 588 | 0.040 |
Why?
|
| Viscosity | 1 | 2021 | 36 | 0.040 |
Why?
|
| Chromosomes | 1 | 2021 | 139 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2021 | 38 | 0.040 |
Why?
|
| Prolyl Hydroxylases | 1 | 2021 | 3 | 0.040 |
Why?
|
| Purkinje Cells | 1 | 2003 | 166 | 0.040 |
Why?
|
| Anaerobiosis | 1 | 2021 | 15 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2021 | 42 | 0.040 |
Why?
|
| Flavoring Agents | 1 | 2020 | 4 | 0.040 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2021 | 22 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 118 | 0.040 |
Why?
|
| Aspergillus niger | 1 | 2020 | 17 | 0.040 |
Why?
|
| Prebiotics | 1 | 2021 | 28 | 0.040 |
Why?
|
| Superovulation | 1 | 2020 | 12 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 182 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 861 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2021 | 309 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 764 | 0.040 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 22 | 0.040 |
Why?
|
| Particle Size | 1 | 2021 | 149 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 57 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2020 | 158 | 0.040 |
Why?
|
| Blastocyst | 1 | 2020 | 78 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2021 | 68 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2021 | 124 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2021 | 197 | 0.040 |
Why?
|
| Embryo Transfer | 1 | 2020 | 56 | 0.040 |
Why?
|
| Ovary | 1 | 2003 | 369 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2021 | 86 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2012 | 540 | 0.040 |
Why?
|
| Cell Survival | 2 | 2015 | 866 | 0.040 |
Why?
|
| Base Sequence | 2 | 2019 | 2899 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2025 | 1017 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2021 | 212 | 0.040 |
Why?
|
| Poly I-C | 1 | 2019 | 24 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 771 | 0.040 |
Why?
|
| Motor Activity | 1 | 2003 | 523 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2022 | 451 | 0.040 |
Why?
|
| Proteins | 1 | 2005 | 1035 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 1280 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 1077 | 0.040 |
Why?
|
| Keratin-14 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Fruit | 1 | 2020 | 234 | 0.040 |
Why?
|
| Aquaculture | 1 | 2018 | 8 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2021 | 433 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2023 | 1121 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 815 | 0.040 |
Why?
|
| Phenotype | 2 | 2019 | 4526 | 0.040 |
Why?
|
| Clathrin | 1 | 2018 | 24 | 0.040 |
Why?
|
| Hydrazones | 1 | 2018 | 19 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 123 | 0.040 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 26 | 0.040 |
Why?
|
| Aminopyridines | 1 | 2018 | 56 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2018 | 11 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 664 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 271 | 0.040 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2018 | 46 | 0.040 |
Why?
|
| Endocytosis | 1 | 2018 | 126 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 315 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2019 | 615 | 0.040 |
Why?
|
| Placenta | 1 | 2002 | 538 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2019 | 303 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2021 | 471 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 424 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 306 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2011 | 449 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2018 | 124 | 0.030 |
Why?
|
| Models, Biological | 1 | 2002 | 1443 | 0.030 |
Why?
|
| Interleukins | 1 | 2018 | 129 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 635 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 500 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2018 | 302 | 0.030 |
Why?
|
| Fibrosis | 1 | 2018 | 421 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2018 | 357 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2011 | 615 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2025 | 1657 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2018 | 359 | 0.030 |
Why?
|
| Fresh Water | 1 | 2016 | 21 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 93 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 95 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1221 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2015 | 17 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 408 | 0.030 |
Why?
|
| Ecosystem | 1 | 2016 | 107 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2011 | 876 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 2 | 2012 | 438 | 0.030 |
Why?
|
| Herbivory | 1 | 2015 | 11 | 0.030 |
Why?
|
| Antibodies | 2 | 2009 | 365 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 111 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 308 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2015 | 35 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2669 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1033 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 3770 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 236 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 195 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 117 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 260 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2014 | 20 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 238 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 126 | 0.030 |
Why?
|
| Synaptophysin | 1 | 2014 | 19 | 0.030 |
Why?
|
| Multipotent Stem Cells | 1 | 2014 | 26 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 394 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 322 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 157 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1125 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 935 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 164 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 97 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2014 | 65 | 0.030 |
Why?
|
| Pituitary Gland | 2 | 2005 | 81 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2013 | 54 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 249 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 39 | 0.030 |
Why?
|
| Epithelium | 1 | 2014 | 354 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 75 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 21 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2013 | 54 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 349 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 442 | 0.020 |
Why?
|
| Ovariectomy | 2 | 2004 | 169 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 57 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 353 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 990 | 0.020 |
Why?
|
| Genome | 1 | 2015 | 504 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 76 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1580 | 0.020 |
Why?
|
| Age Factors | 1 | 2018 | 2913 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 700 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 677 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 254 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 36 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 98 | 0.020 |
Why?
|
| G1 Phase | 1 | 2011 | 66 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 958 | 0.020 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 14 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 335 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 547 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 319 | 0.020 |
Why?
|
| Receptors, Leptin | 1 | 2010 | 42 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2012 | 332 | 0.020 |
Why?
|
| Copulation | 1 | 2009 | 9 | 0.020 |
Why?
|
| Autoantigens | 1 | 2010 | 106 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2009 | 24 | 0.020 |
Why?
|
| Spermatids | 1 | 2009 | 27 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 233 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 122 | 0.020 |
Why?
|
| Oligospermia | 1 | 2009 | 62 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 688 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 309 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 2009 | 5 | 0.020 |
Why?
|
| Cadherins | 1 | 2010 | 179 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2009 | 17 | 0.020 |
Why?
|
| Methylation | 1 | 2009 | 207 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 37 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 1799 | 0.020 |
Why?
|
| C-Peptide | 1 | 2009 | 109 | 0.020 |
Why?
|
| Rabbits | 1 | 2009 | 673 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2009 | 163 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 301 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2009 | 280 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1122 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 382 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1304 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9952 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 468 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2008 | 368 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 454 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 65 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2005 | 52 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 113 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2005 | 16 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 31547 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 127 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1499 | 0.010 |
Why?
|
| Complement C3 | 1 | 2005 | 51 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2004 | 25 | 0.010 |
Why?
|
| Haploidy | 1 | 2004 | 21 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1548 | 0.010 |
Why?
|
| Prostate | 1 | 2007 | 437 | 0.010 |
Why?
|
| Lactoferrin | 1 | 2005 | 73 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 754 | 0.010 |
Why?
|
| Sperm Count | 1 | 2004 | 91 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 141 | 0.010 |
Why?
|
| Death | 1 | 2004 | 79 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 2003 | 46 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 604 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 65 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2003 | 116 | 0.010 |
Why?
|
| Body Constitution | 1 | 2002 | 42 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2005 | 526 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2002 | 26 | 0.010 |
Why?
|
| Placentation | 1 | 2002 | 60 | 0.010 |
Why?
|
| Child | 1 | 2022 | 25762 | 0.010 |
Why?
|
| Ligation | 1 | 2002 | 140 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2004 | 243 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 613 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 285 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 365 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 441 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 238 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 679 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2002 | 254 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2003 | 506 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 487 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 861 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 6569 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 13019 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6443 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 3175 | 0.010 |
Why?
|
| Middle Aged | 1 | 2009 | 28976 | 0.000 |
Why?
|